Axon Enterprise vs Crane NXT
AXON and CXT side by side, both in fabricated metal products, except machinery and transportation equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AXON and CXT compare
Axon Enterprise is the larger company, worth 7.8 times as much as Crane NXT ($25.6B against $3.3B).
On earnings, Crane NXT is cheaper: it trades at 25.8× trailing earnings, against 101× for Axon Enterprise.
Axon Enterprise grew revenue faster over the last twelve months (33.6% versus 17.5% for Crane NXT).
Axon Enterprise keeps more of each dollar of sales as profit, with a net margin of 7.6% compared with 6.9% at Crane NXT.
Crane NXT pays a dividend yielding 1.2%; Axon Enterprise does not pay one.
Crane NXT scores higher on the StockData Score (12 against 7 for Axon Enterprise), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AXON | CXT |
|---|---|---|
| Size and price | ||
| Market cap | $25.6B | $3.3B |
| Share price | $315.43 | $56.92 |
| Change, 1 year | −44.6% | −7.8% |
| Change, 5 years | 73.4% | −45.1% |
| Beta (5Y) | 1.53 | 0.96 |
| Employees | 5,100 | 2,200 |
| StockData Score | ||
| Total score | 7 | 12 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 1 | 2 (better) |
| Health score | 2 | 4 (better) |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/E | 101× | 25.8× (better) |
| P/S | 7.5× | 1.8× (better) |
| P/B | 6.8× | 2.5× (better) |
| EV/EBITDA | 141× | 8.7× (better) |
| P/FCF | 317× | – |
| FCF yield | 0.32% | – |
| Fair value | $100.83 | $55.08 |
| Margin of safety | −213% | −3.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 33.6% (better) | 17.5% |
| Revenue growth, 5Y average | 32.5% (better) | −10.8% |
| Net income growth (TTM) | 0.54% (better) | −17.1% |
| EPS growth (TTM) | −0.95% (better) | −17.5% |
| EPS growth, 5Y average | – | −4.1% |
| Profitability | ||
| Gross margin | 58.5% (better) | 41.2% |
| Operating margin | 2.0% | 12.7% (better) |
| Net margin | 7.6% (better) | 6.9% |
| FCF margin | 2.4% | – |
| Return on equity | 7.6% | 10.2% (better) |
| Return on invested capital | 1.8% | 15.1% (better) |
| Financial health | ||
| Debt / equity | 0.76 | 0.18 (better) |
| Net debt / EBITDA | 6.35 (better) | −0.05 |
| Interest coverage | 0.6× | – |
| Current ratio | 3.00 (better) | 1.31 |
| Altman Z-score | 4.02 (better) | 1.86 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | – | 1.2% |
| Payout ratio | – | 31.9% |
| Years of dividend growth | – | 2 |
| Dividend growth, 5Y average | – | −16.9% |
| Shareholder yield | 0.00% | 1.2% (better) |
| Ownership | ||
| Held by institutions | 89.1% | 107% |
| Held by insiders | 5.4% | 0.23% |
| Insider net buying, 12 months | −$122M | $1.2M (better) |
| Short interest, % of float | 5.3% | 15.7% |
Go deeper
- AXON stock overview
- AXON income statement
- AXON valuation and score
- CXT stock overview
- CXT income statement
- CXT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.